ArticleAbdominal radiology (New York)2026

CT‑based radiomics of bowel wall at baseline predicts the efficacy of Ustekinumab at week 16 in patients with Crohn's disease.

Minyi Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.